AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Candy Preferences to Pharma Insights
This chapter starts with a playful debate on candy preferences, transitioning into a serious analysis of Lilly's earnings report and its implications due to market dynamics and supply chain issues. It examines recent performances in the pharmaceutical sector, focusing on obesity drugs and market competition among companies like Pfizer, Amgen, and Merck.